<span>Russell Phillip Grant, PhD</span>

Russell Phillip Grant, PhD

Vice President of Research and Development
Phone Number: 336-436-3605
Email: [email protected]

Dr. Grant earned a first-class honors degree in Industrial Chemistry from Cardiff University and a PhD in Chromatographic and Mass Spectrometric technologies from the University of Swansea, Wales, United Kingdom. He continued his scientific training in various industrial settings, which have included senior scientist at GSK, Principal scientist at Cohesive Technologies, Technical director at Eli Lilly, and Director of Mass Spectrometry at Esoterix Endocrinology.

Dr Grant is currently the Vice President of Research and Development and co-discipline director for Mass spectrometry at Labcorp. Dr Grant has pioneered the use of direct injection technologies, chromatographic systems multiplexing, microsampling, utility of automation, and other new analytical platforms in direct patient care. His research goals are focused upon improvements in speed, sensitivity, and quality of liquid chromatography with tandem mass spectrometric (LC-MS/MS) analytical systems and assays.

Dr Grant has been awarded over 100 patents and received both the MSACL Distinguished Contribution Award and ASMS AL Yergey “Unsung Hero” Award in 2024 for his contributions to Clinical Diagnostics using Mass Spectrometry.

Publications

  1. Providing absolute certainty without absolute quantity
  2. Liberate, equilibrate and automate: Immunosuppressant analysis in whole blood
  3. Controlling variance for self-collected plasma; anatomy, analysis and accuracy
  4. Proteomic genotyping: When quantitation doesn't matter, but quality still does
  5. Everything you wanted to know about internal standards, but were too afraid to ask
  6. Paint by numbers…coloring within the lines
  7. Genotyping apolipoprotein L1 (ApoL1) from dry plasma with proteomics
  8. The beauty of LC-MS/MS taming the beast of lipophilic vitamins
  9. Don’t know activity from ADAM(TS13)? The first LC-MS/MS assay for measuring activity of von Willebrand factor cleaving protease
  10. Systematic troubleshooting of assay weakness during method development